콘텐츠로 건너뛰기
Merck
  • UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.

UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients.

Oncotarget (2017-11-09)
Corina T Madreiter-Sokolowski, Balázs Győrffy, Christiane Klec, Armin A Sokolowski, Rene Rost, Markus Waldeck-Weiermair, Roland Malli, Wolfgang F Graier
초록

Cancer cells have developed unique strategies to meet their high energy demand. Therefore, they have established a setting of Ca

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
MISSION® esiRNA, targeting human UCP2